Mouse Monoclonal Tenascin C antibody. Suitable for WB, IHC-Fr and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Native Full Length Protein corresponding to Human TNC.
View Alternative Names
HXB, TNC, Tenascin, TN, Cytotactin, GMEM, GP 150-225, Glioma-associated-extracellular matrix antigen, Hexabrachion, JI, Myotendinous antigen, Neuronectin, Tenascin-C, TN-C
- IHC-Fr
Unknown
Immunohistochemistry (Frozen sections) - Anti-Tenascin C antibody [EB2] (AB88280)
ab88280, staining Tenascin C in vulva carcinoma frozen tissue sections by Immunohistochemistry.
- WB
Lab
Western blot - Anti-Tenascin C antibody [EB2] (AB88280)
False colour image of Western blot : Anti-Tenascin C antibody [EB2] staining at 1/1000 dilution, shown in green; Rabbit anti-ACTN4 [EPR2533(2)] (ab108198) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab88280 was shown to bind specifically to Tenascin C. A band was observed at 200/270 kDa in treated wild-type U-2 OS cell lysates with no signal observed at this size in TNC knockout cell line ab262488 (knockout cell lysate ab263924). To generate this image, wild-type and TNC knockout U-2 OS cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 2 % BSA in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent ab133456) and imaged with 16 minutes exposure time. Secondary antibodies used were HRP conjugated Goat anti-Mouse (H+L) and Goat anti-Rabbit IgG H&L (IRDye® 680RD) preabsorbed (ab216777) at 1/20000 dilution.
All lanes:
Western blot - Anti-Tenascin C antibody [EB2] (ab88280) at 1/1000 dilution
Lane 1:
Wild-type U-2 OS Treated BFA (5 ug/mL, 6 h) cell lysate at 40 µg
Lane 2:
TNC knockout U-2 OS Treated BFA (5 ug/mL, 6 h) cell lysate at 40 µg
Lane 2:
Western blot - Human TNC (Tenascin C) knockout U-2 OS cell line (<a href='/en-us/products/cell-lines/human-tnc-tenascin-c-knockout-u-2-os-cell-line-ab262488'>ab262488</a>)
Lane 3:
Wild-type U-2 OS Vehicle Control BFA (0 ug/mL, 6 h) cell lysate at 40 µg
Lane 4:
TNC knockout U-2 OS Vehicle Control BFA (0 ug/mL, 6 h) cell lysate at 40 µg
Lane 5:
U-87 MG Treated BFA (5ug/mL, 6h) cell lysate at 40 µg
Lane 6:
U-87 MG cell lysate at 40 µg
Predicted band size: 241 kDa
Observed band size: 200 kDa,270 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The large hexamer known as Tenascin C plays a significant role in modulating cell adhesion migration and proliferation especially during developmental processes and injury responses. It incorporates into the existing extracellular matrix as a loose network which provides elasticity and supports cellular activities. This feature allows Tenascin C to interact with other matrix molecules and cell surface receptors to regulate tissue morphogenesis.
Pathways
Tenascin C actively participates in the Wnt and TGF-beta signaling pathways important for controlling cellular behavior in development and regeneration. It associates with integrins and glycoproteins to influence cell responses to signaling events in these pathways. By modulating these interactions Tenascin C can impact processes such as epithelial-to-mesenchymal transition and angiogenesis affecting tissue architecture and function.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Endocrinology 166: PubMed39951495
2025
Applications
Unspecified application
Species
Unspecified reactive species
Acta biomaterialia 164:363-376 PubMed37116636
2023
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 62:19 PubMed33595614
2021
Applications
Unspecified application
Species
Unspecified reactive species
Archives of toxicology 94:2423-2434 PubMed32661687
2020
Applications
Unspecified application
Species
Unspecified reactive species
Experimental eye research 182:182-193 PubMed30953624
2019
Applications
Unspecified application
Species
Unspecified reactive species
Tissue engineering. Part A 18:2549-58 PubMed22780864
2012
Applications
Unspecified application
Species
Unspecified reactive species
Investigative ophthalmology & visual science 53:4975-85 PubMed22743323
2012
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com